《盈警》领航医药生物科技(00399.HK)估计全年转蚀最少5.5亿元

阿斯达克财经

2025/06/24

领航医药生物科技(00399.HK) 发盈警，与上年度净利润9,870万元相比，预计3月止财政年度亏损介乎5.5亿至6亿元。预期亏损主要源于与口服胰岛素产品研发进程相关的无形资产减值损失介乎2.5亿至3.5亿元；及可换股债券产生的有效利息支出约2.59亿元。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/11/29中期业绩无派息2024/06/28末期业绩无派息...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2545544627"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2545544627\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2545544627?lang=zh_CN&edition=fundamental","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141800042_s.png","is_english":false,"pubTime":"2025-06-24 00:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2545544627","market":"sh","top_or_hot":-1,"title":"《盈警》领航医药生物科技(00399.HK)估计全年转蚀最少5.5亿元","media":"阿斯达克财经","content":"<div>\n<p>领航医药生物科技(00399.HK) 发盈警，与上年度净利润9,870万元相比，预计3月止财政年度亏损介乎5.5亿至6亿元。预期亏损主要源于与口服胰岛素产品研发进程相关的无形资产减值损失介乎2.5亿至3.5亿元；及可换股债券产生的有效利息支出约2.59亿元。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/11/29中期业绩无派息2024/06/28末期业绩无派息...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448629/latest-news/AAFN\">网页链接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《盈警》领航医药生物科技(00399.HK)估计全年转蚀最少5.5亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《盈警》领航医药生物科技(00399.HK)估计全年转蚀最少5.5亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-24 00:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448629/latest-news/AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>领航医药生物科技(00399.HK) 发盈警，与上年度净利润9,870万元相比，预计3月止财政年度亏损介乎5.5亿至6亿元。预期亏损主要源于与口服胰岛素产品研发进程相关的无形资产减值损失介乎2.5亿至3.5亿元；及可换股债券产生的有效利息支出约2.59亿元。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/11/29中期业绩无派息2024/06/28末期业绩无派息...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448629/latest-news/AAFN\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1124","symbol_name":"贸易公司与经销商","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448629/latest-news/AAFN","article_id":"2545544627","we_media_id":null,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141800042_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448629/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2545544627","pubTimestamp":1750696260,"columns":[],"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"领航医药生物科技(00399.HK) 发盈警，与上年度净利润9,870万元相比，预计3月止财政年度亏损介乎5.5亿至6亿元。预期亏损主要源于与口服胰岛素产品研发进程相关的无形资产减值损失介乎2.5亿至3.5亿元；及可换股债券产生的有效利息支出约2.59亿元。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/11/29中期业绩无派息2024/06/28末期业绩无派息2023/11/29中期业绩无派息2023/06/29末期业绩无派息AASTOCKS新闻","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1124":"贸易公司与经销商","00399":"星太链集团"},"translate_title":"\"Profit Warning\" Pilot Pharmaceutical Biotechnology (00399. HK) estimates that the annual loss will be at least 550 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00399":1},"content_text":"领航医药生物科技(00399.HK) 发盈警，与上年度净利润9,870万元相比，预计3月止财政年度亏损介乎5.5亿至6亿元。预期亏损主要源于与口服胰岛素产品研发进程相关的无形资产减值损失介乎2.5亿至3.5亿元；及可换股债券产生的有效利息支出约2.59亿元。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/11/29中期业绩无派息2024/06/28末期业绩无派息2023/11/29中期业绩无派息2023/06/29末期业绩无派息AASTOCKS新闻","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}